LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 233 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.68 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $242,000 | +11.0% | 1,566 | 0.0% | 0.04% | 0.0% |
| Q3 2021 | $218,000 | +6.3% | 1,566 | 0.0% | 0.04% | +5.9% |
| Q2 2021 | $205,000 | -14.2% | 1,566 | 0.0% | 0.03% | -22.7% |
| Q1 2021 | $239,000 | +12.2% | 1,566 | 0.0% | 0.04% | -30.2% |
| Q4 2018 | $213,000 | -50.5% | 1,566 | 0.0% | 0.06% | -41.7% |
| Q3 2018 | $430,000 | +32.7% | 1,566 | 0.0% | 0.11% | +25.6% |
| Q2 2018 | $324,000 | +51.4% | 1,566 | 0.0% | 0.09% | +45.8% |
| Q4 2017 | $214,000 | +5.9% | 1,566 | -6.0% | 0.06% | +3.5% |
| Q2 2017 | $202,000 | -1.0% | 1,666 | -16.6% | 0.06% | -19.7% |
| Q3 2016 | $204,000 | -14.3% | 1,998 | 0.0% | 0.07% | -16.5% |
| Q2 2016 | $238,000 | +11.2% | 1,998 | 0.0% | 0.08% | +3.7% |
| Q1 2016 | $214,000 | -1.4% | 1,998 | 0.0% | 0.08% | -7.9% |
| Q4 2015 | $217,000 | -33.8% | 1,998 | -81.0% | 0.09% | -41.8% |
| Q1 2015 | $328,000 | – | 10,530 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VILLERE ST DENIS J & CO LLC | 518,988 | $80,162,000 | 4.60% |
| Knott David M Jr | 75,000 | $11,585,000 | 3.93% |
| Orchard Capital Management, LLC | 68,596 | $10,595,000 | 3.11% |
| Chicago Capital, LLC | 436,456 | $67,415,000 | 2.51% |
| RICE HALL JAMES & ASSOCIATES, LLC | 347,699 | $53,706,000 | 1.91% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 85,990 | $13,282,000 | 1.46% |
| Smith, Graham & Co., Investment Advisors, LP | 87,392 | $13,499,000 | 1.34% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 44,754 | $6,913,000 | 1.12% |
| WOODSTOCK CORP | 68,666 | $10,606,000 | 1.11% |
| Stephens Investment Management Group LLC | 411,359 | $63,539,000 | 0.82% |